Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

By Cantarovich M.   Quantz M.   Elstein E.   Ergina P.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 446-448

Elsevier

Access to resources Recommend Favorite

clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients

By Barakat O.   Peaston R.   Rai R.   Talbot D.   Manas D.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1535-1537

Elsevier

Access to resources Recommend Favorite

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

By Marcen R.   Pascual J.   Tato A.   Villafruela J.J.   Teruel J.L.   Rivera M.E.   Tenorio M.   Fernandez M.   Burgos F.J.   Ortuno J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1780-1782

Elsevier

Access to resources Recommend Favorite

Neoral (cyclosporine) C 2 monitoring in renal transplant recipients: a single-center experience in Asia

By Wong H.-S.   Morad Z.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 230-231

Elsevier

Access to resources Recommend Favorite

C 2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients

By Weber L.T.   Shipkova M.   Armstrong V.W.   Mehls O.   Oellerich M.   Tonshoff B.   German Study Group Pediatric Renal Transplantation  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2128-2130

Elsevier

Access to resources Recommend Favorite